2025 Expert Speaker Faculty

Take a look at the esteemed speaker faculty for the 2025 9th IPF Summit.

Jalpa Patel

Global Director, Scientific, Specialty Pipeline, Medical Affairs
Abbvie

Eric Stephen White

Senior Clinical Program Lead
Boehringer Ingelheim

Susanne Dr. Stowasser

Associate Head of Medicine TA Inflammation
Boehringer Ingelheim

Darrell Kotton

Professor of Medicine & Director of the Center for Regenerative Medicine (CReM)
Boston University and Boston Medical Center

Aditya Patel

Executive Director, Pulmonary Clinical Development
Bristol Myers Squibb

Jonas Hallén

Chief Medical Officer & Co-Founder
Calluna Pharma

Robin Mansukhani

Chief Executive Officer
Deciduous Therapeutics

Min Lu

Executive Director
Eli Lilly & Co.

Paul Ford

Former Chief Medical Officer
Galecto

Eugenia Ruiz

Chief Scientific Officer
GAT Therapeutics

David Salzman

Founder & Chief Executive Officer
GATEHOUSE BIO

Olivia Grace Edwards

Program Director
Hanson Wade

Kai Lin

Chief Scientific Officer
HEC Pharm

Carol Ann Satler MD PhD

SVP, Clin DEv and Head Global Development Non-Oncology
Insilico Medicine

Raghu Kumar

Senior Scientist
Ionis Pharmaceuticals, Inc.

Travis Barr

Principal Scientist - Discovery Cardiometabolic Disease
Merck & Co

Lee Borthwick

Chief Scientific Officer, FibroFind & Senior Lecturer, Fibrosis Biology
Newcastle University

Diana Julie Leeming

Senior Director, Hepatic & Pulmonary Research
Nordic Bioscience

Elizabeth Estes

Executive Director
OSIC ILD

Cara WILLIAMS

VP
Pfizer

Peter Schafer

Chair, Prognostic Lung Fibrosis Consortium (PROLIFIC)
Pulmonary Fibrosis Foundation

Camilla Graham

Senior Vice President, Medical Affairs
PureTech Health

Simon LF Walsh

Chief Scientific Officer
Qureight

Cory Hogaboam

Chief Scientific Officer
Rein Therapeutics

Marco Quarta

Co-Founder & Chief Scientific Officer
Rubedo Life Sciences Inc

Lorna Harries

Professor of Molecular Genetics, University of Exeter and Founder and Chief Scientific Officer
SENISCA

Dori Thomas-Karyat

Chief Executive Officer
Synthis Therapeutics, Inc

James Cassella

Chief Development Officer
Trevi Therapeutics

Ole J. Kaasboell

CSO
Tribune Therapeutics

Franck Rahaghi

Executive Director - Cardiopulmonary & Global Medical Affairs
United Therapeutics Corp.

Mary Strek

Professor of Medicine, Director, Interstitial Lung Disease Program
University of Chicago

Joyce Lee

Professor
University of Colorado Denver

Fernando Martinez

Vice chair
University of Massachusetts Medical School

Justin Oldham

Associate Professor & Director, Interstitial Lung Disease Research
University of Michigan

Emilie Millaire

Pulmonologist
University of Montreal

Toby Maher

Professor of Clinical Medicine
University of Southern California

Ahmed Mousa

CEO
Vicore Pharma Holding

Bertil Lindmark

Chief Medical Officer
Vicore Pharma Holding
IPFsummit-66
Explore the Agenda

Hear the latest industry breakthroughs and gain exclusive regulatory insights during our packed agenda, interactive roundtables, and new CXOs’ panel discussion.

View Presentations & Speakers
IPFsummit-213
Partner With Us

Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.

Explore Sponsorship Options
IPFsummit-274
Join Biopharma Experts

Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.

Register Interest